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Knowledge about juvenile idiopathic
arthritis-associated uveitis: more frequent
reminders are associated with higher
patient and family uveitis knowledge
Ashley M. Cooper1,2* , Elaine R. Flanagan3, Tova Ronis4, Baruch Goldberg3, Ashley K. Sherman1, Chelsey Smith1,
Gary N. Holland5 and for the CARRA Uveitis Workgroup

Abstract
Background: Chronic anterior uveitis is a sight-threatening complication of juvenile idiopathic arthritis (JIA) and a
primary contributor to long-term morbidity in people with JIA. Levels of knowledge about uveitis among JIA
patients and their parents are unknown. A survey of JIA patients and parents was conducted to assess knowledge
about uveitis complications and recommended screening.
Methods: A survey was developed consisting of six demographic questions, six arthritis/uveitis history questions,
and nine uveitis knowledge questions. The survey was administered to JIA patients age 14 and older and parents of
patients with JIA at three pediatric rheumatology practices and online through the Patients, Advocates, and
Rheumatology Teams Network for Research and Service (PARTNERS) network. ANOVA, chi-square and Fisher’s exact
tests were used to look for relationships between survey questions and demographic variables.
Results: Thirty-three patients and 111 parents completed the survey. Overall, 17.4% reported a history of uveitis,
and 89.6% had heard of uveitis. The mean composite knowledge score was 6.46 ± 2.6 out of 9. Patients and parents
with a history of uveitis had higher composite knowledge scores than their counterparts without a uveitis history
(p = 0.01 and p < 0.01, respectively). Parents whose rheumatologist reminded them about eye exams at every visit
had higher knowledge of the risk of blindness (p = 0.04), the risk for uveitis when arthritis is controlled (p = 0.02), the
need for ongoing eye exams when off of medications (p = 0.01), and had a higher overall score (p = 0.02) than
those who were reminded at some visits or not at all.
Conclusions: JIA patients and parents report variable levels of knowledge regarding uveitis complications and
recommended screening. Frequent discussion between the rheumatology provider and family about uveitis
screening is associated with higher uveitis knowledge. Incorporating detailed and frequent education about uveitis
into rheumatology clinic appointments may improve early uveitis detection and visual outcomes.
Keywords: Uveitis, Juvenile arthritis, Patient education

* Correspondence: amcooper@cmh.edu
1
Children’s Mercy Kansas City, 2401 Gillham Rd, Kansas City, MO 64108, USA
2
University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
Full list of author information is available at the end of the article
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.

Cooper et al. Pediatric Rheumatology

(2021) 19:149

Background
Juvenile idiopathic arthritis (JIA) is the most common
rheumatic disease of childhood. In addition to joint inflammation, 10–20% of children with JIA develop
chronic anterior uveitis [1, 2]. Although JIA-associated
uveitis is often asymptomatic early in the disease course,
it can lead to visual compromise through the development of cataracts, glaucoma, macular edema, band keratopathy, and inflammatory membranes in up to 70% of
patients [3–7]. Screening for uveitis consists of measuring immune cells and protein (“flare”) in aqueous humor
of the anterior chamber of the eye, as seen by slit lamp
biomicroscopic exam per the Standardized Uveitis Nomenclature (SUN) criteria and evaluating visual acuity
and ocular pressure [8]. The current screening algorithm
developed for the American Academy of Pediatrics
(AAP) recommends screening patients every 3–12
months depending on known risk factors: arthritis subtype, antinuclear antibody (ANA) status, age of arthritis
onset, and time since arthritis onset [9]. In 2019, the
American College of Rheumatology published guidelines
that included similar uveitis screening intervals for JIA
patients and specified screening intervals for JIAassociated uveitis patients during periods of disease control and medication tapering [10].
Identification of uveitis through screening before
symptoms of vision loss are clinically apparent is critical
for early treatment and prevention of complications.
There is minimal information in the published literature
about rates of adherence to recommended eye screening
among patients with JIA. Ballenger, et al. examined barriers to uveitis screening at a single center, where 37% of
patients with JIA were nonadherent to the recommended screening interval and over one-fourth of patients were not familiar with the recommended
frequency of eye exams [11]. A detailed assessment of
patient knowledge about the complications of uveitis
and the exam components which are necessary to adequately screen for uveitis was not included in that
study.
The Childhood Arthritis and Rheumatology Research
Alliance (CARRA) Uveitis Workgroup is comprised of
pediatric rheumatologists and ophthalmologists with expertise or special interest in childhood uveitis. The clinical
experience of the workgroup suggested that JIA patients
and parents have poor understanding of potential complications of uveitis, as well as timing and required components of uveitis screening exams. The goal of this survey
was to assess JIA patient and parent knowledge about uveitis complications and screening recommendations.
Methods
In this survey of uveitis knowledge, patients and parents
of patients with JIA were recruited from pediatric
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rheumatology clinics at three geographically-diverse academic centers (Children’s Mercy Kansas City, Children’s
National Hospital, Washington, DC, and Children’s
Healthcare of Atlanta/Emory University), and online
through the PARTNERS (Patients, Advocates and Research Teams Network for Research and Service) collaborative, a patient-powered research network. Respondent
inclusion criteria were the following: adolescents and
young adults with JIA (age 14 or older) and parents of
JIA patients of any age, who could complete a survey in
English.
This study was approved by the Institutional Review
Boards of the participating sites and documentation of
consent/assent was waived.

Survey design

Patients and parents of patients with JIA were
approached to complete the uveitis survey during regularly scheduled pediatric rheumatology clinic visits or
completed the survey online through PARTNERS. For
recruitment in clinics, only one participant was recruited
from each family (an age-eligible patient or a parent).
Participants completed a 21-item survey developed by
the CARRA Uveitis Workgroup to assess respondent
knowledge about uveitis risks, complications, and
screening recommendations and procedures. The survey
included six demographic questions, six arthritis/uveitis
history questions, and nine uveitis knowledge questions.
Additional file 1 shows the detailed survey content [see
additional file 1] Knowledge questions addressed issues
such as potential development of cataracts, glaucoma,
and blindness, as well as participant knowledge of the
required components of a full ophthalmologic screening
visit for uveitis: slit lamp biomicroscopy and intraocular
pressure determination. The survey was pilot tested by
several parents of JIA patients at one of the participating
sites. Feedback from this pilot testing was used to improve the survey design prior to initiating recruitment.
Study data were collected anonymously and managed
using REDCap (Research Electronic Data Capture) electronic data capture tools hosted at Children’s Mercy
Kansas City [12, 13]. REDCap is a secure, web-based
software platform designed to support data capture for
research studies, providing 1) an intuitive interface for
validated data capture; 2) audit trails for tracking data
manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for data
integration and interoperability with external sources. As
a composite measure, an overall knowledge score was
calculated by summing the number of correct individual
knowledge questions resulting in a range of 0–9
(Table 1).
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Table 1 Uveitis knowledge assessment and composite score
Question

Score

1. Have you heard of uveitis (an eye disease that can happen in people with arthritis)?

__/ 1

2. Did you know that uveitis can cause cataracts (clouding of the lens)?

__/ 1

3. Did you know that uveitis can cause glaucoma (eye damage from high pressure)?

__/ 1

4. Did you know that uveitis can cause blindness?

__/ 1

5. Did you know that children with arthritis can get uveitis even when their arthritis is controlled?

__/ 1

6. Did you know that children with arthritis need eye screening even if they have no eye symptoms?

__/ 1

7. Did you know that children with arthritis need eye exams even if they are no longer on medications for arthritis?

__/ 1

8. Did you know that a slit lamp is needed for a full eye exam for uveitis? (picture was shown)

__/ 1

9. Did you know that a pressure check is needed for a full exam for uveitis? (pictures of instruments used to check pressure were shown)

__/ 1

Composite Score

__/ 9

Descriptive statistics such as means, standard deviations, and proportions were used to summarize the data.
Associations between demographic or historical features
and individual knowledge questions or composite scores
were analyzed using chi-square, the Fisher exact, t-tests
or ANOVA. P values less than 0.05 were considered significant. SAS, version 9.4 (SAS Institute Inc., Cary, NC),
was used for all analyses.

Results
Thirty-three patients and 111 parents completed the
survey in clinic or online through PARTNERS. There

was one missing response to 4 different questions, otherwise the data was complete. Demographic data are summarized in Table 2, stratified by identity (patient or
parent) and location of survey completion (clinic or online). Respondents from all groups were predominantly
female (126/144, 87.5% overall) and Caucasian (123/144,
85.4% overall) with a relatively high educational level
(62/144, 43.1% college graduates and an additional 36/
144, 25% with post-graduate education).
A total of 128 respondents (88.9%) reported that they/
their child is treated for JIA by pediatric rheumatology,
13 (9%) by adult rheumatology, 2 (1.4%) by a primary

Table 2 Demographic information of patient and parent respondents stratified by location of survey completion
Patients

Parents

Demographics

Clinic (n = 21)

Online (n = 12)

Clinic (n = 47)

Online (n = 64)

Age, median (IQR)

17 (14–19)

26 (23–39.50)

38.5 (36–44)

42 (37–48)

Female, n (%)

17 (81)

11 (91.7)

38 (80.9)

60 (93.8)

1 (4.8)

0

3 (6.4)

1 (1.6)

Race/Ethnicity
African American
Asian

0

0

4 (8.5)

1 (1.6)

Hispanic

1 (4.8)

2 (16.7)

2 (4.3)

1 (1.6)

Caucasian

18 (85.7)

10 (83.3)

38 (80.9)

57 (89.1)

Other

1 (4.8)

0

0

4 (6.3)

Midwest

5 (23.8)

3 (25)

22 (46.8)

23 (35.9)

Northeast

3 (14.3)

2 (16.7)

7 (14.9)

23 (35.9)

Southeast

13 (61.9)

3 (25)

18 (38.3)

10 (15.6)

Other

0

4 (33.3)

0

8 (12.5)

Geographic Location

Educational Level
Some HS/HS grad

4 (19.1)

0

5 (10.6)

2 (3.1)

Some college/trade

7 (33.3)

3 (25)

12 (25.5)

13 (20.3)

College grad

6 (28.6)

5 (41.7)

22 (46.8)

29 (45.3)

Postgrad

4 (19.1)

4 (33.3)

8 (17)

20 (31.3)
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care provider, and 1 (1.4%) by “other” (comments indicate ophthalmology in partnership with pediatric
rheumatology). Among all respondents, 143 (99.3%) had
at least one eye exam and 25 (17.4%) reported a history
of uveitis.
Among all participants, 89.6% had heard of uveitis,
though knowledge of potential uveitis complications and
screening recommendations were lower in all groups
(Table 3). The mean composite score was 6.46 (SD 2.6)
out of 9. Parent respondents who completed the survey
online through PARTNERS had a higher composite
score (mean 7.22) than parents completing the survey in
clinic or patients completing the survey through PARTNERS or in clinic (means of 5.96, 5.92, 5.57, respectively)
(p = 0.02, although no pairwise differences were
significant).
Patients with a history of uveitis had higher composite
knowledge scores than those without a uveitis history
(8.3 vs. 5, p = 0.01). The same was true for parents who
reported a history of uveitis in their child (8.6 vs. 6.3,
p < 0.01). More parents who reported that their rheumatologist reminded them about eye exams at every visit
were aware of: the risk of blindness (85.5% vs. 68.6%,
p = 0.04), the risk for uveitis even when arthritis is controlled (81.3% vs. 60%, p = 0.02), and the need for ongoing eye exams when off medications (81.6% vs. 57.1%,
p = 0.01) than those who received occasional or no reminders from their rheumatologist. They also had a
higher overall knowledge score (mean 7.1 vs. 5.9, p =
0.02). Differences in knowledge related to frequency of
eye exam reminders did not reach statistical significance
in the patient group. There was a trend toward higher
composite scores among college graduates when compared to non-college graduates, although the difference
did not reach statistical significance. (mean 6.7 vs. 5.9,
p = 0.07).
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Discussion
Uveitis is a major source of morbidity in JIA patients.
Regular screening is required to detect JIA-associated
uveitis during the asymptomatic phase, allow timely
treatment, and prevent ocular complications. JIA patients receive multi-disciplinary care and parents and patients are a vital bridge between providers. It is essential
that they are informed about uveitis risks and necessary
screening to function optimally as advocates for their
health.
We found no prior articles describing a similar multicenter assessment of uveitis knowledge base in JIA patients on a computerized literature search using
PubMed. In this geographically diverse cohort, we demonstrated that knowledge about uveitis screening recommendations, eye exam components, and potential uveitis
complications is variable among JIA patients and their
parents. Patients and parents of patients with a history
of uveitis had higher overall knowledge of uveitis. This
finding is not surprising as patients who have been diagnosed with uveitis would likely have discussed the uveitis
diagnosis in more detail with their providers, attended
more frequent eye exams, and discussed or even experienced complications of uveitis, such as a cataract or
glaucoma.
The other factor associated with increased uveitis
knowledge among JIA patients and parents was receiving
reminders about eye exams at every rheumatology visit.
In addition to overall knowledge, reminders were specifically associated with improved understanding of the
risks of uveitis when arthritis is controlled and when off
of arthritis medications. Understanding of these concepts is crucial for parents and young adult patients to
remain vigilant about routine eye exams even during periods of inactive arthritis to promote long term ocular
health.

Table 3 Results of individual uveitis knowledge survey questions and composite scores
Positive Responses to Knowledge Questions (%)
Question (abbreviated)

Patients
Clinic
(n = 21)

Parents
Online
(n = 12)

Clinic
(n = 47)

Total
Online
(n = 64)

Have you heard of uveitis?

71.4

100

91.5

92.2

89.6

Did you know uveitis can cause cataracts?

42.9

50

38.3

64.1

51.4

Did you know uveitis can cause glaucoma?

52.4

41.7

46.8

73.4

59

Did you know uveitis can cause blindness?

66.7

83.3

68.1

89.1

78.5

Did you know uveitis can occur when JIA is controlled?

47.6

66.7

63

82.8

69.9

Did you know eye exams are needed even if no eye symptoms?

71.4

83.3

93.6

92.2

88.9

Did you know eye exams are needed even if off arthritis medications?

57.1

58.3

68.1

78.1

70.1

Did you know a slit lamp is needed for screening?

81

50

76.6

82.8

77.8

Did you know a pressure check is needed for screening?

66.7

58.3

55.3

67.2

62.5

Composite Score, mean (sd)

5.57 (3.3)

5.92 (2.2)

5.96 (2.3)

7.22 (2.6)

6.46 (2.6)
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This project was initially pursued to assess the accuracy of the project team’s anecdotal experience that uveitis knowledge is suboptimal in JIA patients and parents.
The question regarding eye exam reminders was included in this survey to assess whether discussions about
uveitis in the rheumatology office had measurable impact on knowledge base. The findings of this study suggest that regular reminders about eye exams by
rheumatologists affect overall uveitis knowledge. Given
the long-term therapeutic relationships between JIA
families and their rheumatology providers, the rheumatology clinic may be an optimal setting for a targeted
intervention to further increase uveitis knowledge and
adherence with ophthalmology exams.
There were several limitations of this study. The respondent population lacked diversity with respect to gender and ethnicity, though as several subtypes of JIA are
more prevalent in females and Caucasians, this finding is
not surprising. Though there was geographic diversity
among respondents, the Northwest and Southwest were
underrepresented. The goal of including patients from
across the United States was to capture practice pattern
variation across different rheumatology centers, which
was likely achieved with this respondent group.
Several limitations may have contributed to an overestimate of uveitis knowledge in this study cohort as
compared to the larger JIA population. Survey questions
were worded using the structure “Did you know”
followed by a true statement to avoid risk to participants
of being misinformed about uveitis as a result of study
participation. This approach may have introduced bias
leading to over-reporting of uveitis knowledge. The
study population was limited to those who could
complete the survey in English. Patients and families
with limited English proficiency may face additional barriers to gaining knowledge about JIA-associated uveitis
as compared to our study population. As patients and
parents with higher levels of education were overrepresented, the level of uveitis knowledge and understanding may not be fully generalizable to the overall JIA
population. The skewed educational background may
over-estimate uveitis knowledge among the larger JIA
population rather than under-estimating it. This effect
was suggested by a trend towards higher composite
scores in the college graduates, though the difference
did not reach statistical significance. Similarly, respondents from PARTNERS, who are highly engaged advocates for JIA research and care, may be more
knowledgeable about uveitis than most JIA families.
Some of the patient participants recruited through
PARTNERS are now adults, raising the possibility of recall bias.
Recruiting participants from PARTNERS was extremely valuable, allowing inclusion of highly motivated
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patients and parents from more sites; however, a limitation of this approach was the inability to definitively verify the diagnosis of JIA in the PARTNERS participants.
Finally, it was impossible to determine if the respondents
were up to date on their eye exams without access to
multiple clinical characteristics that the uveitis screening
recommendations are based upon: JIA subtype, age at
diagnosis, ANA status, and time since diagnosis.

Conclusions
Patients and parents of patients with JIA were aware of
uveitis, but the depth of knowledge varied. Factors associated with a higher knowledge about uveitis complications and screening recommendations were a personal
history of uveitis and eye exam reminders at every
rheumatology visit. Incorporating standardized and frequent education about uveitis into rheumatology clinic
appointments may be an effective strategy to improve
knowledge about uveitis and subsequently visual outcomes in JIA patients, as early diagnosis and treatment
is critical for retention of vision. Future directions for
this work include development and testing of standardized patient education tools.
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